| NCT Number | NCT07013578 |
| Lead Sponsor | TIDHI Innovation Inc.
Collaborators: Amgen, Celltrion |
| Conditions | Crohn Disease (CD), Ulcerative Colitis (UC), Inflammatory Bowel Disease (IBD) |
| Enrollment | 100 participants |
| Start Date | 2025-07-22 |
| Primary Completion | 2026-12-31 (estimated) |
| Study Completion | 2027-07-01 (estimated) |
| Updated on ClinicalTrials.gov | 2025-08-11 |